Nerve block may cut opioid use for cancer pain

NCT ID NCT07211386

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nerve block called the erector spinae plane block can reduce abdominal pain in people with gastrointestinal cancer. Researchers will compare opioid use and hospital stay length between 25 patients who get the block and a matched group who received standard care. The goal is to see if this procedure can offer effective pain relief with fewer opioids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
erector spinae plane block (a nerve block procedure)
What this could lead to
If it works, this could offer a non-opioid option for managing severe abdominal pain in people with gastrointestinal cancer.
What could go wrong
This is a small, early study with only 25 participants, so results may not apply to everyone. The nerve block may not provide enough pain relief for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital of the University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Hospital of the University of Pennsylvania -- Cedar Avenue

    RECRUITING

    Philadelphia, Pennsylvania, 19143, United States

  • Penn Presbyterian Medical Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Pennsylvania Hospital

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.